Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDFIP2 antisense RNA 1 (NDFIP2-AS1) is a long non-coding RNA (lncRNA) gene locus situated antisense to the NDFIP2 (Nedd4 Family Interacting Protein 2) coding gene. The biological function, mechanistic effects, and potential roles in human disease for this lncRNA have not been characterized in primary literature or major gene annotation databases as of 2025[3][6]. It is not a protein, enzyme, receptor, transporter, or recognized therapeutic target, and there are no described interactions with drugs, nor is it known to serve as a clinical biomarker or to confer safety concerns. NDFIP2-AS1 is distinct from the protein-coding NDFIP2 gene, which regulates pathways involving E3 ubiquitin ligases, but no similar information exists for the antisense RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NDFIP2 antisense RNA 1 (non-protein coding) (NDFIP2-AS1).